Article
Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2016
Miao Xiaobing, Xu Xiaohong, Wu Yaxun, Zhu Xinghua, Chen Xudong, Li Chunsun, Lu Xiaoyun, Chen Yali, Liu Yushan, Huang Jieyu, Wang Yuchan, He Song
Abstract excerpt
Recent studies have identified that thyroid hormone receptor-interacting protein 6 (TRIP6) is implicated in tumorigenesis. However, the functional role of TRIP6 in non-Hodgkin's lymphoma (NHL) has never been elucidated. In this study, we demonstrated that TRIP6 is reversely correlated with the clinical outcomes of NHL patients. Western blot and immunohistochemical analysis revealed that TRIP6 expression is lower...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
